Diseases, Conditions, Syndromes

Positive results for Lilly and Regeneron COVID antibodies

US pharmaceutical company Eli Lilly's combination of two synthetic antibodies against COVID-19 reduced hospitalizations and deaths by 70 percent in high-risk patients with recent positive tests, the company said Tuesday.

Oncology & Cancer

The behavior of therapeutic antibodies in immunotherapy

Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells. However, in the more than 20 years since ...

Diseases, Conditions, Syndromes

Redirecting the natural immune response to disrupt bacterial biofilms

Most bacterial species prefer to live in biofilms, where they are protected from antibiotic treatments and can lead to chronic and recurrent diseases in humans. To address this problem, researchers at Nationwide Children's ...

Diseases, Conditions, Syndromes

Researchers produce six antibodies to combat Zika virus

Researchers have generated six Zika virus antibodies that could be used to test for and possibly treat a mosquito-borne disease that has infected more than 1.5 million people worldwide.

Diseases, Conditions, Syndromes

Delivering antibodies via mRNA could prevent RSV infection

Almost every child gets respiratory syncytial virus (RSV), which causes cold-like symptoms. It's usually not a big deal if they're healthy, but every year in the U.S. some 57,000 children under the age of five are hospitalized ...

page 1 from 2